Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

Abstract

Meningiomas are common central nervous system tumours which present usually in the 4th and 5th decades of life. Loss of constitutional heterozygosity on chromosome 22 in 60% of sporadic meningiomas has implied the involvement of a tumour suppressor gene. The neurofibromatosis type 2 gene (NF2), a prime candidate for involvement in meningioma, was screened for point mutations. After examining eight of the 16 known NF2 exons in 151 meningiomas, 24 inactivating mutations were characterized. Significantly, these aberrations were exclusively detected in tumours which lost the other chromosome 22 allele. These results provide strong evidence that the suppressor gene on chromosome 22, frequently inactivated in meningioma, is the NF2 gene, and suggest that another gene is involved in the development of 40% of meningiomas.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Weinberg, R.A. Tumor suppressor genes. Science 254, 1138–1146 (1991).

    Article  CAS  PubMed  Google Scholar 

  2. Klein, G. The approaching era of the tumor suppressor genes. Science 238, 1539–1545 (1987).

    Article  CAS  PubMed  Google Scholar 

  3. Fearon, E.R. et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247, 49–56 (1990).

    Article  CAS  PubMed  Google Scholar 

  4. Horowitz, J.M. et al. Point mutational inactivation of the retinoblastoma antioncogene. Science 243, 937–940 (1989).

    Article  CAS  PubMed  Google Scholar 

  5. Kaye, F.J., Kratzke, R.A., Gerster, J.L. & Horowitz, J.M. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylatlon and oncoprotein binding. Proc. natn. Acad. Sci. U.S.A. 87, 6922–6926 (1990).

    Article  CAS  Google Scholar 

  6. Van Heyningen, V. & Hastie, N.D. Wilm's tumour: reconciling genetics and biology. Trends Genet. 8, 16–21 (1992).

    Article  CAS  PubMed  Google Scholar 

  7. Cawthon, R.M. et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structre and point mutations. Cell 62, 193–201 (1990).

    Article  CAS  PubMed  Google Scholar 

  8. Li, Y. et al. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69, 275–281 (1992).

    Article  CAS  PubMed  Google Scholar 

  9. Martuza, R.L. & Eldridge R Neurofibromatosis 2 (Bilateral acoustic neurofibromatosis). New Engl. J. Med. 318, 684–688 (1988).

    Article  CAS  PubMed  Google Scholar 

  10. Wertelecki, W. et al. Neurofibromatosis 2: Clinical and DNA linkage studies of a large kindred. New Engl. J. Med. 319, 278–283 (1988).

    Article  CAS  PubMed  Google Scholar 

  11. Rouleau, G.A. et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363, 515–521 (1993).

    Article  CAS  PubMed  Google Scholar 

  12. Trofatter, J.A. et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72, 791–800 (1993).

    Article  CAS  PubMed  Google Scholar 

  13. Evans, D.G.R. et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J. med. Genet. 29, 847–852 (1992).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kepes, J.J. in Meningiomas: Biology pathology differential diagnosis (Masson, New York, 1982).

    Google Scholar 

  15. Seizinger, B.R., de la Monte, S., Atkins, L., Gusella, J.F. & Martuza, R.L. Molecular genetic approach to human meningioma: Loss of genes on chromosome 22. Proc. natn. Acad. Sci. U.S.A. 84, 5419–5423 (1987).

    Article  CAS  Google Scholar 

  16. Dumanski, J.P., Caribom, E., Collins, VP. & Nordenskjöld, M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc. natn. Acad. Sci. U.S.A. 84, 9275–9279 (1987).

    Article  CAS  Google Scholar 

  17. Ruttledge, M.H. et al. Deletions on chromosome 22 in sporadic meningioma. Genes Chrom. Cancer (in the press).

  18. Dumanski, J.P., Rouleau, G.A., Nordenskjold, M. & Collins, V.P. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma Cancer Res. 50, 5863–5867 (1990).

    CAS  PubMed  Google Scholar 

  19. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. & Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. natn. Acad. Sci. U.S.A. 86, 2766–2770 (1989).

    Article  CAS  Google Scholar 

  20. Sanger, F. Determination of nucleotide sequences in DNA. Science 214, 1205–1210 (1981).

    Article  CAS  PubMed  Google Scholar 

  21. Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomes 5, 874–879 (1989).

    Article  CAS  Google Scholar 

  22. Orita, M., Sekiya, T. & Hayashi, K. DNA sequence polymorphisms in Alu repeats. Genomics 8, 271–278 (1990).

    Article  CAS  PubMed  Google Scholar 

  23. Sarkar, G., Yoon, H-S. & Sommer, S.S. Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP. Nucl. Acids Res. 20, 871–878 (1992).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Sheffield, V.C., Beck, J.S., Kwitek, A.E., Sandstrom, D.W. & Stone, E.M. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16, 325–332 (1993).

    Article  CAS  PubMed  Google Scholar 

  25. Pulst, S.M., Rouleau, G.A., Marineau, C., Fain, P. & Sieb, J.P. Familial meningioma is not allelic to neurofibromatosis 2. Neurology 43, 2096–2098 (1993).

    Article  CAS  PubMed  Google Scholar 

  26. Fearon, E.R. & Vogelstein, B. A genetic model for tumorigenesis. Cell 61, 759–767 (1990).

    Article  CAS  PubMed  Google Scholar 

  27. Bishop, J.M. Molecular themes in oncogenesis. Cell 64, 235–248 (1991).

    Article  CAS  PubMed  Google Scholar 

  28. Casalone, R. et al. Recessive cancer genes in meningiomas? An analysis of 31 cases. Cancer genet. Cytogenet. 27, 145–159 (1987).

    Article  CAS  PubMed  Google Scholar 

  29. Al Saadi, A., Latimer, F., Madercic, M. & Robbins, T. Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. Cancer genet. Cytogenet. 26, 127–141 (1987).

    Article  CAS  PubMed  Google Scholar 

  30. Dumanski, J.P., Carlborn, E., Collins, V.P. & Nordenskjöld, M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc. natn. Acad. Sci. U.S.A. 84, 9275–9279 (1987).

    Article  CAS  Google Scholar 

  31. Bergerheim, U., Nordenskjöld, M. & Collins, V.P. Deletion mapping in human renal cell carcinoma. Cancer Res. 49, 1390–1396 (1989).

    CAS  PubMed  Google Scholar 

  32. Sambrook, J., Fittsch, E.F. & Maniatis, T. . in Molecular cloning: A laboratory manual 5.31–10.17 (Cold Spring Harbor Laboratory Press, New York, 1989).

    Google Scholar 

  33. Hultman, T., Stahl, S., Homes, E. & Uhlen, M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucl. Acids Res. 17, 4937–4946 (1989).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Hultman, T., Bergh, S., Moks, T. & Uhlen, M. Bidirectional solid phase sequencing of in vitro amplified plasmid DNA. Biotechniques 10, 1, 84–93 (1991).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruttledge, M., Sarrazin, J., Rangaratnam, S. et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6, 180–184 (1994). https://doi.org/10.1038/ng0294-180

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0294-180

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing